Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108558715A details high-yield route. Reduces cost and environmental impact for pharmaceutical intermediates manufacturing significantly.
Patent CN109456211A enables high-purity synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Deep dive into CN104072390B. Advanced impurity control for S-escitalopram. Reliable supply chain and cost-effective manufacturing solutions for global pharma.
Patent CN101787032A reveals a cost-effective clopidogrel synthesis using D-camphorsulfonic acid resolution, offering high purity and scalable manufacturing for global supply chains.
Patent CN115010686A details a novel resolution for 2-oxabicyclo-[3.3.0]oct-6-en-3-one, offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN101910124A details a high-purity 3-aminopyrrolidine salt production via MPAA resolution, offering cost-effective aqueous processing for pharmaceutical intermediates.
Novel epoxidation-ring opening route for antiviral intermediates. Reduces cost and improves purity compared to lithium aluminum hydride methods. Reliable supplier.
Advanced preparation method for Non-neridone intermediates via CN116082334A. High-yield resolution and scalable cyanation for cardiovascular API manufacturing.
Patent CN109232184B details a chiral resolution method for L-isopulegol ensuring high optical purity and yield suitable for industrial menthol production.
Patent CN1161689A enables high-purity levobupivacaine production with reduced resolving agent usage and improved supply chain reliability for pharmaceutical manufacturers globally.
Patent CN101570550A details a scalable, chromatography-free route for chiral ferrocene ligands, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel chiral resolving agent enables high-purity (R)-o-chloromandelic acid production. Mature industrial route ensures supply chain stability and cost efficiency for pharmaceutical intermediates.
Patent CN101007772B reveals a cost-effective Strecker synthesis for chiral norvaline, offering significant supply chain advantages for perindopril manufacturing.
Patent CN105348172B details a green synthesis route for Apremilast intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112939911A reveals a novel chiral resolution process for L-Corey lactone intermediates, offering high optical purity and scalable manufacturing for prostaglandin synthesis.
Patent CN119613414A reveals high-yield Fezolinetant route. Offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN1759097A details a safer process for PDF inhibitor intermediates using specific beta-lactams and selective debenzylation, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Discover the advanced atmospheric pressure synthesis of (2S)-indoline-2-carboxylic acid. A cost-effective, high-purity route for Perindopril intermediates suitable for industrial scale-up.
Novel chiral auxiliary method for rasagiline production offering high yield and reduced pollution for pharmaceutical manufacturers seeking reliable supply chains.
Patent CN108586517B details a cost-effective route for 4-AA using chiral resolution, offering reliable supply and reduced heavy metal contamination for API manufacturers.